FindTrial
Sign In

Precise Quantification of LA-NSCLC Heterogeneity and Prediction of Treatment Response and Prognosis Based on 18F-FDG PET/CT Metabolic Habitat Imaging

Precise Quantification of LA-NSCLC Heterogeneity and Prediction of Treatment Response and Prognosis Based on 18F-FDG PET/CT Metabolic Habitat Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122525
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case series:NA

Sponsors

the Second Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with LA-NSCLC; 2. No other primary tumors; 3. Patients with newly diagnosed tumors; 4. 18F-FDG PET/CT images available before treatment for tumor patients; 5. Complete clinical and follow-up data for patients.

Exclusion criteria

Exclusion criteria: 1. History of prior antitumor therapy; 2. Presence of another primary malignant tumor; 3. PET/CT image quality insufficient for radiological analysis (e.g., inadequate for contour delineation); 4. Lack of follow-up data; 5. Follow-up CT image quality insufficient for response assessment.

Design outcomes

Primary

MeasureTime frame
SUVmax;SUVpeak;SUVmean;TLG;MTV;—

Countries

China

Contacts

Public ContactYu Ji

the Second Qilu Hospital of Shandong University

jysdey@163.com+86 157 5318 8006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026